GlassScriptPhysician profile
Maria E Arredondo
NPI 1942569553
$10,426.93
in general payments reported to CMS, 2019-2025
40 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,141 · 2022: $2,127 · 2023: $2,883 · 2024: $2,536 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,158.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,131.28 | 2021-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $1,079.86 | 2021-2025 | Farxiga, Lokelma, Breztri |
| Esperion Therapeutics, INC. | $823.06 | 2021-2023 | Nexlizet, Nexletol |
| Genzyme Corporation | $811.26 | 2023-2024 | |
| Amgen INC. | $706.20 | 2023-2025 | Repatha, Otezla |
| Lilly USA, LLC | $662.00 | 2022-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $656.69 | 2021-2022 | |
| Dexcom, INC. | $487.29 | 2022-2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $377.68 | 2022-2023 | Krystexxa, Tepezza |
| Glaxosmithkline, LLC. | $285.68 | 2021-2023 | Arexvy |
| Regeneron Healthcare Solutions, INC. | $254.88 | 2025 | Dupixent |
| Nestle Healthcare Nutrition INC. | $233.83 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.34 | 2023-2024 | Jardiance |
| Exact Sciences Corporation | $218.94 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $206.66 | 2022-2025 | Verquvo, Gardasil 9, Capvaxive |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Arredondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.